Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 6,070.00
-100.00 (-1.62%)
At close: Sep 4, 2026
Wonbiogen Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 41,312 | 47,383 | 40,723 | 60,375 | 58,397 | 74,002 | |
Market Cap Growth | 4.94% | 16.36% | -32.55% | 3.39% | -21.09% | - |
Enterprise Value | 34,611 | 33,914 | 33,158 | 60,117 | 59,424 | 68,665 |
Last Close Price | 6070.00 | 6680.00 | 5624.71 | 8193.91 | 7941.21 | 9595.46 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.03 | 7.16 | 7.16 | 10.98 | 18.21 | - |
Forward PE | - | 6.38 | 6.38 | 5.79 | 8.87 | - |
PS Ratio | 1.09 | 1.34 | 1.34 | 2.04 | 2.18 | 4.18 |
PB Ratio | 0.92 | 1.11 | 1.09 | 1.85 | 2.18 | 2.79 |
P/TBV Ratio | 0.93 | 1.12 | 1.12 | 1.93 | 2.25 | 2.87 |
P/FCF Ratio | - | 7.28 | 4.97 | 18.93 | - | - |
P/OCF Ratio | 3.94 | 5.59 | 4.60 | 12.49 | 10.10 | 68.39 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.92 | 0.96 | 1.09 | 2.03 | 2.22 | 3.88 |
EV/EBITDA Ratio | 3.14 | 3.50 | 4.22 | 6.99 | 9.51 | 23.51 |
EV/EBIT Ratio | 3.65 | 4.14 | 5.33 | 8.54 | 11.77 | 33.66 |
EV/FCF Ratio | - | 5.21 | 4.04 | 18.85 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.02 | 0.02 | 0.22 | 0.34 | 0.31 |
Debt / EBITDA Ratio | 0.41 | 0.10 | 0.11 | 0.85 | 1.47 | 2.77 |
Debt / FCF Ratio | - | 0.14 | 0.11 | 2.30 | - | - |
Net Debt / Equity Ratio | -0.15 | -0.34 | -0.27 | -0.04 | 0.02 | -0.21 |
Net Debt / EBITDA Ratio | -0.59 | -1.49 | -1.27 | -0.14 | 0.10 | -1.94 |
Net Debt / FCF Ratio | 4.44 | -2.22 | -1.22 | -0.39 | -0.88 | 4.52 |
Asset Turnover | 0.77 | 0.79 | 0.72 | 0.72 | 0.70 | 0.62 |
Inventory Turnover | 2.92 | 3.06 | 2.57 | 2.40 | 2.66 | 2.96 |
Quick Ratio | 2.35 | 4.63 | 4.77 | 1.45 | 1.03 | 1.61 |
Current Ratio | 3.25 | 6.00 | 6.55 | 2.26 | 1.57 | 2.10 |
Return on Equity (ROE) | 20.07% | 16.17% | 15.28% | 20.05% | 12.26% | -5.11% |
Return on Assets (ROA) | 12.31% | 11.52% | 9.23% | 10.75% | 8.20% | 4.45% |
Return on Invested Capital (ROIC) | 23.29% | 24.51% | 17.61% | 19.92% | 18.64% | 17.71% |
Return on Capital Employed (ROCE) | 20.60% | 19.00% | 16.40% | 21.00% | 18.50% | 7.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 20.39% | 13.96% | 13.97% | 9.11% | 5.49% | -0.97% |
FCF Yield | -3.60% | 13.74% | 20.14% | 5.28% | -1.22% | -1.69% |
Dividend Yield | 2.28% | - | - | 1.22% | 0.63% | - |
Payout Ratio | 11.71% | 10.72% | 12.46% | 6.36% | - | - |
Buyback Yield / Dilution | 1.64% | 0.03% | 6.72% | -5.70% | -3.58% | -49.52% |
Total Shareholder Return | 3.92% | 0.03% | 6.72% | -4.48% | -2.95% | -49.52% |